Group 1 - The core viewpoint of the news highlights the performance and recognition of Pumen Technology in the medical device industry, showcasing its financial metrics and recent accolades [1][2]. - As of August 4, Pumen Technology's stock closed at 13.93 yuan, with a rolling PE ratio of 20.45 times and a total market capitalization of 5.969 billion yuan [1]. - The average PE ratio for the medical device industry is 54.32 times, with a median of 38.11 times, placing Pumen Technology at the 44th position in the industry ranking [1][3]. Group 2 - Pumen Technology specializes in the research, manufacturing, global sales, and service of in vitro diagnostics, clinical medicine, skin aesthetics, and consumer health products [2]. - The company has received multiple awards, including the "Smart Health Elderly Care Application Pilot Demonstration - Demonstration Enterprise" from three ministries and the "2023 China Corrosion and Protection Society Science and Technology Award" for its project on superhydrophobic coatings [2]. - In the latest quarterly report for Q1 2025, Pumen Technology reported a revenue of 215 million yuan, a year-on-year decrease of 29.69%, and a net profit of 53.6847 million yuan, down 49.93%, with a gross profit margin of 64.97% [2].

Core Viewpoint - Company Pumen Technology (688389.SH) has received FDA 510(k) certification for its semiconductor laser hair removal device, indicating compliance with U.S. regulatory standards and enabling market access in the U.S. [1] Group 1 - The FDA certification is a significant milestone for the company, marking an important step in its international expansion strategy [1] - This certification is expected to enhance the company's capabilities in expanding its overseas market presence [1] - The development is viewed positively for the company's international business growth [1]

证券代码：688389 证券简称：普门科技 公告编号：2025-059 深圳普门科技股份有限公司 关于自愿披露公司产品获得美国FDA 510(k)认证 的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 近日，深圳普门科技股份有限公司（以下简称"公司"）收到 U.S. Food and Drug Administration（美国食品药品监督管理局，以下简称"FDA"）的通知， 公司半导体激光脱毛仪获得了美国 FDA 510(k)认证。具体情况如下： 一、获证产品的基本信息 二、对公司的影响 本次获得美国 FDA 510(k)认证，表明公司半导体激光脱毛仪符合美国食品 药品监督管理局的相关要求，获得美国市场的准入资格。本次获得认证是公司 国际化布局的重要组成部分，有利于进一步提升公司海外市场拓展能力，对公 司国际业务发展具有积极作用。 三、风险提示 上述产品在美国市场的实际销售情况受海外法规政策、市场环境变化、市 场推广情况以及汇率波动等多方面因素的影响，目前尚无法预测其对公司未来 业绩的具体影响。敬请广大投资者理性投 ...

Core Viewpoint - Company Pumen Technology (688389.SH) has received FDA 510(k) certification for its semiconductor laser hair removal device, indicating compliance with U.S. regulatory standards and enabling market access in the U.S. [1] Group 1 - The FDA certification is a significant milestone for the company's international expansion strategy [1] - This certification enhances the company's capability to penetrate overseas markets [1] - The development is expected to positively impact the company's international business growth [1]

Group 1 - The company, Pumen Technology (688389.SH), has received notification from the U.S. Food and Drug Administration (FDA) regarding the approval of its semiconductor laser hair removal device, which has obtained FDA 510(k) certification [1]

Core Viewpoint - The company, Pumen Technology (688389.SH), has received FDA 510(k) certification for its semiconductor laser hair removal device, indicating regulatory approval for its product in the U.S. market [1]. Company Summary - Pumen Technology announced the receipt of FDA notification regarding the approval of its semiconductor laser hair removal device [1].

Core Viewpoint - The company, Pumen Technology (688389), has received FDA 510(k) certification for its semiconductor laser hair removal device, allowing it to enter the U.S. market [1] Company Summary - Pumen Technology announced on August 4 that it has obtained FDA 510(k) certification for its semiconductor laser hair removal device [1]

Core Viewpoint - Company Pumen Technology (688389) has received FDA 510(k) certification for its semiconductor laser hair removal device, allowing entry into the U.S. market [1] Group 1 - The FDA notification confirms that the company's product meets the necessary regulatory requirements for safety and effectiveness [1] - This certification is a significant milestone for the company, potentially enhancing its market presence and sales opportunities in the U.S. [1]

Core Viewpoint - Pumen Technology's stock closed at 13.78 yuan, with a rolling PE ratio of 20.23 times, significantly lower than the industry average of 53.65 times, indicating potential undervaluation in the medical device sector [1][3]. Company Overview - Pumen Technology specializes in the research, manufacturing, global sales, and service of in vitro diagnostics, clinical medicine, skin aesthetics, and consumer health products [2]. - The company's main products include medical products, home products, testing equipment, and testing reagents [2]. Recent Achievements - In January 2024, Pumen Technology was awarded the "Smart Health Elderly Care Application Pilot Demonstration - Demonstration Enterprise" by three ministries [2]. - The project "Micro-tube Inner Surface Wear-resistant Superhydrophobic Coating and Its Application in Medical Devices" won the "2023 China Corrosion and Protection Society Science and Technology Award" first prize [2]. - Pumen's subsidiary, Guangdong Pumen Biomedical Technology Co., Ltd., was recognized as a "Specialized, Refined, Characteristic, and Innovative Small and Medium-sized Enterprise" by the Guangdong Provincial Department of Industry and Information Technology [2]. - A collaborative project with Chongqing University on "Key Technology Development and Industrialization of Fully Automatic Specific Protein Analyzer" received the "2023 China Industry-University-Research Cooperation Innovation Achievement Award" second prize [2]. Financial Performance - In Q1 2025, Pumen Technology reported revenue of 215 million yuan, a year-on-year decrease of 29.69%, and a net profit of 53.68 million yuan, down 49.93% [2]. - The company's gross profit margin stood at 64.97% [2]. Market Position - As of March 31, 2025, Pumen Technology had 13,289 shareholders, an increase of 3,464 from the previous period, with an average holding value of 352,800 yuan and an average holding of 27,600 shares per shareholder [1].

金融界消息 截至2025年7月29日收盘，普门科技（688389）报收于13.86元，上涨0.14%，换手率 1.49%，成交量6.37万手，成交金额8793.96万元。 资金流向方面，今日主力资金净流出1840.87万元，占比成交额20.93%。其中，超大单净流出694.14万 元、占成交额7.89%，大单净流出1146.73万元、占成交额13.04%，中单净流出流入651.83万元、占成交 额7.41%，小单净流入1189.04万元、占成交额13.52%。 普门科技最新一期业绩显示，截至2025一季报，公司营业总收入2.15亿元、同比减少29.69%，归属净利 润5368.47万元，同比减少49.93%，扣非净利润4995.98万元，同比减少51.63%，流动比率2.751、速动比 率2.502、资产负债率26.13%。 天眼查商业履历信息显示，深圳普门科技股份有限公司，成立于2008年，位于深圳市，是一家以从事研 究和试验发展为主的企业。企业注册资本42848.573万人民币，实缴资本10061.884万人民币。公司法定 代表人为刘先成。 通过天眼查大数据分析，深圳普门科技股份有限公司共对外投资了17家 ...